Hostname: page-component-7b7567c8c-tnzcf Total loading time: 0 Render date: 2026-11-14T16:18:40.872Z Has data issue: false hasContentIssue false
  • English
  • Français

Collaborative care at the crossroads

Published online by Cambridge University Press:  02 January 2018

Peter Roy-Byrne
Peter Roy-Byrne*
Affiliation:
University of Washington School of Medicine, At Harborview Medical Center, Box 35-9911, 325 9th Avenue, Seattle, Washington, USA. Email: roybyrne@u.washington.edu
Rights & Permissions [Opens in a new window]

Summary

Collaborative care is a well-studied and effective model of integrating behavioural healthcare into primary care medical settings. Despite evidence of its effectiveness, it has been difficult to implement into the US healthcare system. The upcoming reorganisation of US healthcare will rely heavily on adaptations of this model to improve its uptake and cost-effectiveness.

Information

Type
Editorials
Information
The British Journal of Psychiatry , Volume 203 , Issue 2 , August 2013, pp. 86 - 87
Copyright
Copyright © Royal College of Psychiatrists, 2013 

The collaborative care model for delivering evidence-based treatments for depression in the primary care setting, a model shown to be effective in multiple meta-analyses, is now almost 20 years old. Reference Katon, von Korff, Lin, Walker, Simon and Bush1 This model was originally developed to address the problem that many patients with depression, unable to be seen by the inadequate number of mental health specialists in the USA, failed to receive effective treatment (principally medication) despite its wide availability. The collaborative care model emphasised the use of a care manager to facilitate measurement-based outcomes monitoring and patient self-management (e.g. treatment adherence), along with access to specialty consultation. Reference Woltmann, Grogan-Kaylor, Perron, Georges, Kilbourne and Bauer2 Care manager and specialist also served to facilitate ‘stepped care’, where patients failing to improve were re-evaluated and then ‘stepped up’ to more or different treatments in an attempt to improve outcomes. In some later collaborative care model iterations, care managers delivered evidence-based psychotherapies, providing another treatment option. Reference Roy-Byrne, Craske, Sullivan, Rose, Edlund and Lang3 More recently, the model has been extended beyond depression to include patients with anxiety disorders, alcohol misuse, chronic pain and severe mental illness.

Implementation challenges

Despite the scientific evidence that this approach works, implementation of this model for mental disorders in the USA has been particularly difficult (it has been more easily implemented for chronic medical illnesses such as diabetes). The compromised motivational and cognitive states of patients, the existence of multiple psychiatric diagnoses demanding some kind of ‘cross-diagnostic’ or multiple comorbidity approach, the separation of behavioural and medical health systems and philosophies, and the fragmentation of the US mental health system, including the separation of substance misuse and mental health models and systems of care, have all contributed. A lack of organisational ‘readiness to change’ (including providers, ancillary staff, financing incentives and administrative processes) has also played a dominant role, along with concerns about cost.

A recent study of the uptake of three integrated mental healthcare models in one of the few US single organisation, single-payer health systems, the Veterans Health Administration, Reference Chang, Rose, Yano, Wells, Metzger and Post4 showed that adoption was greatest (47%) for a crude ‘collocation’ model (mental health specialist in the clinic) compared with two models requiring more change in the care process (17% and 7%). These low-uptake models were more similar to the collaborative care model and likely to be more effective, and yet were much harder to implement. Cost concerns will be even more paramount with the upcoming reorganisation of US healthcare, posing a risk that watered-down versions of the collaborative care model that have not been scientifically tested will be adopted for expediency. Measurement-based outcome tracking will certainly survive because, with electronic medical record improvements, it will be cost-neutral. In contrast, the type and extent of care manager training and the nature and extent of expert consultation (both carrying significant costs) will be debated. Although a recent meta-analysis of the collaborative care model calls for more research to test ‘moderators and mechanisms’, Reference Woltmann, Grogan-Kaylor, Perron, Georges, Kilbourne and Bauer2 there are limited resources and time for more research and, given the adaptations required for implementation, it is certain that adoption will proceed as it usually does in business, with iterative qualitative improvement efforts to test what works and what is cost-effective in that business context. The rise of accountable care organisations will hopefully link payment to outcomes and drive further use of this model. Consistent with this, a study Reference Unutzer, Chan, Hafer, Knaster, Shields and Powers5 nicely demonstrated that pay for performance can improve patient follow-up and depression outcomes using this model.

Collaborative care facilitation

The study by Oosterbaan and colleagues, Reference Oosterbaan, Verbraak, Terluin, Hoogendoorn, Peyrot and Muntingh6 in this issue of the Journal, contains some novel and important elements that should be carefully considered as healthcare organisations look for better ways to implement the collaborative care model. These include its cluster-randomised design (by clinic rather than patient), its broad-based diagnostic focus, its formal inclusion of and linkage with the specialty mental healthcare system, its inclusion of a formal symptom severity strategy for assigning the initial ‘step’ of care, and its use of less-costly guided self-help workbooks to facilitate entry-level treatment. If there are to be any further randomised controlled trials of the collaborative care model, they should only occur in large systems that can randomise by clinic rather than patient, as Oosterbaan et al did, making the study of possible moderators of uptake possible. Identifying organisational aspects that facilitate adoption will likely be more crucial than studies of patient-level moderators. Although Oosterbaan et al broaden the focus of the collaborative care model beyond depression to anxiety and stress, further broadening is needed to include both common behavioural (e.g. substance misuse, pain) and medical (e.g. diabetes, cardiac disease) comorbidities (see the work now being done in implementing the Katon TEAMcare model of collaborative care for patients with depression, diabetes and heart disease Reference Katon, Lin, Von Korff, Ciechanowski, Ludman and Young7 ). The collaborative care model must link strongly with available specialty care (likely more easy in the European setting than in the Balkanised US system), and must exploit the use of technology in novel ways. The workbook strategy employed here could be done via web-based application. A recent study Reference Fortney, Pyne, Mouden, Mittal, Hudson and Schroeder8 has suggested that centralised care manager and specialist availability (these could be done via web or video-conferencing platforms), could be more efficient, cheaper and even more effective in rural areas, removing the need for each clinic and system to incorporate new personnel. In contrast to the method used by Oosterbaan et al, one study suggests that severity of symptoms may not be an ideal method for determining who would best respond to a first step of care - i.e. patients who are more severely symptomatic may also respond to initial step care. Reference Bower, Kontopantelis, Sutton, Kendrick, Richards and Gilbody9 Finally, although the short-term results of Oosterbaan et al's study are encouraging, the absence of longer-term benefit is concerning. This calls to mind the literature on surgery for low back pain, which shows improved outcomes in the short run but not at 1 year. It will be hard to recommend a model of service delivery without significant staying power, even as we understand these results as the outcome of gradual improvement in usual care patients over time. However, other collaborative care model studies have shown continued beneficial effects at 1 year, albeit with lower effect sizes, Reference Roy-Byrne, Craske, Sullivan, Rose, Edlund and Lang3,Reference Unützer, Katon, Callahan, Williams, Hunkeler and Harpole10 so the jury is still out.

In the USA, we now await a grand experiment where we try to provide physical and mental healthcare for larger numbers of citizens, and to find ways to more efficiently and cost-effectively provide the best possible care. It seems a certainty that the collaborative care model will be employed in various forms and iterations to facilitate initial behavioural healthcare access, to promote astute use of evidence-based treatment in primary care, and to identify and treat patients in need of further stepped care in primary care or specialty settings. There will be challenges in determining whether the collaborative care model is a ‘one size fits all’ solution, i.e. whether it will provide benefit with certain types of patient populations or care delivery systems (see a recent failure with patients with post-traumatic stress disorder Reference Schnurr, Friedman, Oxman, Dietrich, Smith and Shiner11 ), and if and how much it can supplant or replace mental health specialty care. To ease implementation, future iterations might consider centralised care management using expert care managers and psychiatrists who communicate via telephone, text messaging, email or audio and/or video conferencing over the internet. This would not require a change in clinic personnel or functions, would allow delivery of both cognitive-behavioural therapy and expert medication management, and might simulate more ‘specialty’-oriented care, while at the same time achieving integration with primary medical care.

References

1 Katon, W, von Korff, M, Lin, EH, Walker, ED, Simon, GE, Bush, TM, et al Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA 1995; 273: 1026–31.CrossRefGoogle ScholarPubMed
2 Woltmann, E, Grogan-Kaylor, A, Perron, B, Georges, H, Kilbourne, AM, Bauer, MS. Comparative effectiveness of collaborative chronic care models for mental health conditions across primary, specialty, and behavioral health care settings: systematic review and meta-analysis. Am J Psychiatry 2012; 169: 790–804.CrossRefGoogle ScholarPubMed
3 Roy-Byrne, P, Craske, MG, Sullivan, G, Rose, RD, Edlund, MJ, Lang, AJ, et al Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial. JAMA 2010; 303: 1921–8.CrossRefGoogle ScholarPubMed
4 Chang, ET, Rose, DE, Yano, EM, Wells, KB, Metzger, ME, Post, EP, et al Determinants of readiness for primary care-mental health integration (PC-MHI) in the VA Health Care System. J Gen Intern Med 2013; 28: 353–62.CrossRefGoogle ScholarPubMed
5 Unutzer, J, Chan, YF, Hafer, E, Knaster, J, Shields, A, Powers, D, et al Quality improvement with pay-for-performance incentives in integrated behavioral health care. Am J Public Health 2012; 102: e41–5.Google Scholar
6 Oosterbaan, D, Verbraak, MJPM, Terluin, B, Hoogendoorn, AW, Peyrot, WJ, Muntingh, A, et al Collaborative stepped care v. care as usual for common mental disorders: 8-month, cluster randomised controlled trial. Br J Psychiatry 2013; 203: 132–9.Google Scholar
7 Katon, WJ, Lin, EH, Von Korff, M, Ciechanowski, P, Ludman, EJ, Young, B, et al Collaborative care for patients with depression and chronic illnesses. N Engl J Med 2010; 363: 2611–20.CrossRefGoogle ScholarPubMed
8 Fortney, JC, Pyne, JM, Mouden, SB, Mittal, D, Hudson, TJ, Schroeder, GW, et al Practice-based versus telemedicine-based collaborative care for depression in rural federally qualified health centers: a pragmatic randomized comparative effectiveness trial. Am J Psychiatry 2013; 170: 414–25.Google Scholar
9 Bower, P, Kontopantelis, E, Sutton, A, Kendrick, T, Richards, DA, Gilbody, S, et al Influence of initial severity of depression on effectiveness of low intensity interventions: meta-analysis of individual patient data. BMJ 2013; 346: f540.Google Scholar
10 Unützer, J, Katon, W, Callahan, CM, Williams, JWJ, Hunkeler, E, Harpole, L, et al Collaborative care management of late-life depression in the primary care setting. JAMA 2002; 288: 2836–45.Google Scholar
11 Schnurr, PP, Friedman, MJ, Oxman, TE, Dietrich, AJ, Smith, MW, Shiner, B, et al RESPECT-PTSD: re-engineering systems for the primary care treatment of PTSD, a randomized controlled trial. J Gen Intern Med 2013; 28: 32–40.Google Scholar

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.